Skip to content

An Evidence-Based Evaluation Study on the Preventive Effect of Yupingfeng Powder Modified and Subtracted Series Compounds on Influenza Exposure Based on Constitution Theory

Evidence-based evaluation research on common key technical schemes of TCM prevention and treatment of acute respiratory infectious diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003956
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-08-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The life contact (including dining, sleeping together, talking, traveling, etc.) with a confirmed influenza patient before enrollment is >=48 hours but not more than 1 week; 2. The time window from fever to diagnosis of the influenza patient contacted by the subject =18 years old.

Exclusion criteria

Exclusion criteria: 1) Clinically confirmed patients with influenza during the study period; 2) Subjects with flu-like symptoms at the time of enrollment; 3) Subjects who cannot maintain life contact with a confirmed influenza patient within 14 days; 4) Subjects who need to use antipyretic, analgesic, anti-inflammatory drugs, corticosteroids or immunosuppressive agents for any underlying disease; 5) Immunocompromised subjects (including subjects receiving systemic immunosuppressants or subjects infected with human immunodeficiency virus [HIV]); 6) Have received baloxavir (Xofluza), peramivir (Rapiacta), lanemivir (Inavir), oseltamivir (Tamiflu), Subjects treated with zanamivir (RELEZA) or amantadine (Symmetrel); 7) Subjects with known history of allergy to traditional Chinese medicine; 8) Subjects who have taken a Chinese medicine compound with similar effects within 30 days before screening; 9) Women who are pregnant or breastfeeding; 10) Subjects whose investigators consider any conditions or circumstances that would endanger the safety of the subjects or affect the quality of research data.

Design outcomes

Primary

MeasureTime frame
Proportion of patients diagnosed with influenza within 14 days;

Secondary

MeasureTime frame
Proportion of patients with symptoms of acute respiratory infection within 14 days;Proportion of patients with symptomatic influenza infection within 14 days;Time of onset of flu-like symptoms within 14 days;Proportion of patients with asymptomatic influenza infection within 14 days;

Countries

China

Contacts

Public ContactLU ZHEN HUI

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Dr_luzh@shutcm.edu.cn+86 13817729859

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026